Porubsky, David https://orcid.org/0000-0001-8414-8966
Dashnow, Harriet https://orcid.org/0000-0001-8433-6270
Sasani, Thomas A.
Logsdon, Glennis A. https://orcid.org/0000-0003-2396-0656
Hallast, Pille https://orcid.org/0000-0002-0588-3987
Noyes, Michelle D.
Kronenberg, Zev N.
Mokveld, Tom https://orcid.org/0000-0003-1905-5442
Koundinya, Nidhi https://orcid.org/0009-0008-7155-1287
Nolan, Cillian
Steely, Cody J.
Guarracino, Andrea https://orcid.org/0000-0001-9744-131X
Dolzhenko, Egor https://orcid.org/0000-0002-3296-0677
Harvey, William T.
Rowell, William J. https://orcid.org/0000-0002-7422-1194
Grigorev, Kirill
Nicholas, Thomas J.
Goldberg, Michael E.
Oshima, Keisuke K.
Lin, Jiadong
Ebert, Peter https://orcid.org/0000-0001-7441-532X
Watkins, W. Scott
Leung, Tiffany Y.
Hanlon, Vincent C. T. https://orcid.org/0000-0002-2008-8957
McGee, Sean
Pedersen, Brent S. https://orcid.org/0000-0003-1786-2216
Happ, Hannah C.
Jeong, Hyeonsoo
Munson, Katherine M. https://orcid.org/0000-0001-8413-6498
Hoekzema, Kendra
Chan, Daniel D.
Wang, Yanni
Knuth, Jordan
Garcia, Gage H. https://orcid.org/0009-0005-2383-722X
Fanslow, Cairbre
Lambert, Christine
Lee, Charles https://orcid.org/0000-0001-7317-6662
Smith, Joshua D.
Levy, Shawn
Mason, Christopher E. https://orcid.org/0000-0002-1850-1642
Garrison, Erik https://orcid.org/0000-0003-3821-631X
Lansdorp, Peter M. https://orcid.org/0000-0001-7435-1071
Neklason, Deborah W. https://orcid.org/0000-0002-4546-7080
Jorde, Lynn B.
Quinlan, Aaron R. https://orcid.org/0000-0003-1756-0859
Eberle, Michael A.
Eichler, Evan E. https://orcid.org/0000-0002-8246-4014
Article History
Received: 5 August 2024
Accepted: 20 March 2025
First Online: 23 April 2025
Competing interests
: E.E.E. is a scientific advisory board member of Variant Bio. C. Lee is a scientific advisory board member of Nabsys and Genome Insight. D.P. has previously disclosed a patent application (no. EP19169090) relevant to Strand-seq. Z.N.K., C.N., E.D., C.F., C. Lambert, T.M., W.J.R. and M.A.E. are employees and shareholders of PacBio. Z.N.K. is a private shareholder in Phase Genomics. The other authors declare no competing interests.